CATHETER, CANNULA AND TUBING, VASCULAR, CARDIO
Report
- Report Number
- 8010762-2018-00322
- Event Type
- Malfunction
- Date Received
- December 10, 2018
- Date of Event
- November 8, 2018
- Report Date
- April 26, 2019
- Manufacturer
- MAQUET CARDIOPULMONARY AG
- Product Code
- DWF
- PMA / PMN Number
- K102532
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
MAQUET MEDICAL SYSTEMS,USA(IMPORTER)SUBMITS THIS REPORT ON BEHALF OF THE LEGAL MANUFACTURER OF THE DEVICE MAQUET CARDIOPULMONARY (B)(4). RASTATT, GERMANY. A FOLLOW-UP MEDWATCH WILL BE SUBMITTED WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE. REFERENCE EXEMPTION # E2018002. IMPORTER- MAQUET MEDICAL SYSTEMS USA (B)(4). CONTACT PERSON- (B)(6). MAQUET GMBH HAS REQUESTED THE PRODUCT FOR MANUFACTURER INVESTIGATION. HOWEVER,WE WERE INFORMED THAT THE PRODUCT WAS NOT AVAILABLE. BASED ON THE RECEIVED COMPLAINT PICTURE, IT IS CLEARLY SEEN THAT THE SAMPLE WAS CRACKED. ALSO, MAQUET GMBH IS AWARE OF SIMILAR COMPLAINT WHICH WAS REGISTERED AS #(B)(4) .ACCORDING TO LABORATORY INVESTIGATION RESULTS OF (B)(4) ; CLAIMED PART WAS INVESTIGATED. THERE WAS NO SCREW CAP OF THE LUER LOCK ON THE CONNECTOR. SEVERAL CRACKS ON THE LUER LOCK OF THE 3/8X3/8 CONNECTOR WERE DETECTED. LEAK TEST COULD NOT BE CARRIED OUT BECAUSE IT LED TO LEAKAGE THROUGH THE CRACKS. NO FURTHER ABNORMALITIES COULD BE DETECTED. THE FAILURE WAS CONFIRMED BY THE LABORATORY. GETINGE CP ANTALYA HAS BEEN EVALUATED THE PRODUCTION STEPS OF THE SET. THE MOST PROBABLE CAUSE OF THE FAILURE IS FOUND AS MOUNTING FAILURE CAUSED BY OPERATOR. BASED ON THIS FAILURE COULD BE CONFIRMED. SAP TREND SEARCH WAS PERFORMED (MATERIAL 70104.7285, FAILURE CODE CRACK FRACTURE) WHICH CAME TO FOLLOWING RESULTS: 0 ADDITIONAL COMPLAINT WAS RECORDED WHICH APPEARS REPORTED ISSUES ARE THE SAME SINCE THE LAST 12 MONTHS. SAP TREND SEARCH WAS ALSO PERFORMED BASED ON SIMILAR FAILURE CODE AND SAME PRODUCT GROUP.ADDITIONALLY 2 SIMILAR COMPLAINTS WERE FOUND. BASED ON THE SALES FIGURES OF THE LAST 12 MONTHS FOLLOWING OCCURRENCE RATE HAS BEEN CALCULATED: 0,04%, WHICH IS BELOW 1%. DUE TO THIS INFORMATION NO SYSTEMIC ISSUE COULD BE DETERMINED. AS A CORRECTIVE ACTION THE OPERATORS WERE ALREADY TRAINED ABOUT THE SAME FAILURE WHICH WAS REGISTERED AS(B)(4).THE DATA IS BEING HANDLED THROUGH A DESIGNATED MAQUET CARDIOPULMONARY TRENDING AND APPLICABLE INVESTIGATION PROCESS.DUE TO THIS NO FURTHER INVESTIGATIONS WILL BE COMPLETED AS THIS TIME.
THE DEVICE HAS NOT BEEN RETURNED FOR EVALUATION YET. MAQUET CARDIOPULMONARY (B)(4) WILL SUBMIT A SUPPLEMENTAL MEDWATCH ON RECEIPT OF FURTHER INFORMATION. (B)(4). A FOLLOW-UP MEDWATCH WILL BE SUBMITTED WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE. (B)(4). REFERENCE EXEMPTION # E2018002.
REF.: #(B)(4), CUST. REF.:(B)(4).
ACCORDING TO THE HOSPITAL: BLOOD LEAKING DURING ECMO THERAPY. (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 987359 | CATHETER, CANNULA AND TUBING, VASCULAR, CARDIO | CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS | DWF | MAQUET CARDIOPULMONARY AG | BE-PAL 1523#BE-HLS | 92228965 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |